Sonia Prieto-Blanco

Vigo, GA 36310, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis.

Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis.

Journal: BMC cancer
Published: January 12, 2017

Highly Sensitive Marker Panel for Guidance in Lung Cancer Rapid Diagnostic Units.

Highly Sensitive Marker Panel for Guidance in Lung Cancer Rapid Diagnostic Units.

Journal: Scientific reports
Published: July 28, 2016

Serum calprotectin, CD26 and EGF to establish a panel for the diagnosis of lung cancer.

Serum calprotectin, CD26 and EGF to establish a panel for the diagnosis of lung cancer.

Journal: PloS one
Published: November 07, 2014

Pretreatment levels of the serum biomarkers CEA, CYFRA 21-1, SCC and the soluble EGFR and its ligands EGF, TGF-alpha, HB-EGF in the prediction of outcome in erlotinib treated non-small-cell lung cancer patients.

Pretreatment levels of the serum biomarkers CEA, CYFRA 21-1, SCC and the soluble EGFR and its ligands EGF, TGF-alpha, HB-EGF in the prediction of outcome in erlotinib treated non-small-cell lung cancer patients.

Journal: SpringerPlus
Published: September 29, 2014

Levels of PEDF in pleural effusions from lung adenocarcinoma and benign disease patients.

Levels of PEDF in pleural effusions from lung adenocarcinoma and benign disease patients.

Journal: Disease markers
Published: April 19, 2013

Calprotectin: a novel biomarker for the diagnosis of pleural effusion.

Calprotectin: a novel biomarker for the diagnosis of pleural effusion.

Journal: British journal of cancer
Published: October 25, 2012

Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer.

Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer.

Journal: BMC cancer
Published: September 26, 2012

Secreted clusterin in colon tumor cell models and its potential as diagnostic marker for colorectal cancer.

Secreted clusterin in colon tumor cell models and its potential as diagnostic marker for colorectal cancer.

Journal: Cancer investigation
Published: January 13, 2012
Showing 1-8 of 8

Last Updated: 09/26/2026